Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10966562 | Vaccine | 2013 | 11 Pages |
Abstract
⺠From 2007 to 2010, African countries implemented YF preventive vaccination campaigns. ⺠38 million people were vaccinated against YF and 164 serious adverse events observed. ⺠Few serious adverse events results from YF vaccine. ⺠Our results reinforce the generally accepted safety profile of YF vaccine. ⺠The continued use of YF vaccine during preventive vaccination campaigns is supported.
Keywords
RKIAEFIIFAYFVRT-PCRADEMPharmacovigilanceNECImmunofluorescent antibodyacute disseminated encephalomyelitisVaccine safetyYellow feverEnzyme-linked immunosorbent assayELISAAdverse event following immunizationWorld Health Organizationadverse eventCSFCerebrospinal fluidYellow fever vaccinereverse transcription polymerase chain reactionWHO
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
J.G. Breugelmans, R.F. Lewis, E. Agbenu, O. Veit, D. Jackson, C. Domingo, M. Böthe, W. Perea, M. Niedrig, B.D. Gessner, S. Yactayo, on behalf of the YF AEFI group on behalf of the YF AEFI group,